期刊文献+

Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura 被引量:15

Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura
原文传递
导出
摘要 Background Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy. In this study we investigated the von Willebrand factor-cleaving protease (vWF-cp) activity deficiency in patients with TTP.Methods The plasma or serum vWF-cp activity was measured using a sensitive enzyme-linked immunosorbent assay (ELISA) by detecting the residual collagen binding activity (R-CBA) of von Willebrand factor (vWF) before and after digestion by vWF-cp. Multimers of vWF in plasma of patients with TTP were also analyzed by SDS-agarose electrophoresis. Moreover,the serum vWF-cp activities were compared between the patients with TTP and those with tumors.Results The coefficient of variation for intra-batch and inter-batch of the assay were 3.60% and 8.35%. The plasma and serum vWF-cp activity in healthy individuals were (78.79±9.17)% (n=30) and (79.47±10.78)% (n=53),respectively,while the plasma vWF-cp activity in 5 patients with TTP was markedly decreased [(21.83±19.98)%,P <0.001]. The unusually large vWF multimers were observed in two plasma samples of the patients with TTP. Although the vWF-cp activities in patients with benign and malignant tumors were also decreased ( P <0.03 and P <0.001,respectively),they were relatively high in comparison with that of TTP patients ( P <0.001).Conclusion Measurement of the vWF-cp activity using R-CBA is a simple and rapid method for diagnosing TTP. The vWF-cp activity in patients with TTP was markedly lower than those of patients with tumors. Background Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy. In this study we investigated the von Willebrand factor-cleaving protease (vWF-cp) activity deficiency in patients with TTP.Methods The plasma or serum vWF-cp activity was measured using a sensitive enzyme-linked immunosorbent assay (ELISA) by detecting the residual collagen binding activity (R-CBA) of von Willebrand factor (vWF) before and after digestion by vWF-cp. Multimers of vWF in plasma of patients with TTP were also analyzed by SDS-agarose electrophoresis. Moreover,the serum vWF-cp activities were compared between the patients with TTP and those with tumors.Results The coefficient of variation for intra-batch and inter-batch of the assay were 3.60% and 8.35%. The plasma and serum vWF-cp activity in healthy individuals were (78.79±9.17)% (n=30) and (79.47±10.78)% (n=53),respectively,while the plasma vWF-cp activity in 5 patients with TTP was markedly decreased [(21.83±19.98)%,P <0.001]. The unusually large vWF multimers were observed in two plasma samples of the patients with TTP. Although the vWF-cp activities in patients with benign and malignant tumors were also decreased ( P <0.03 and P <0.001,respectively),they were relatively high in comparison with that of TTP patients ( P <0.001).Conclusion Measurement of the vWF-cp activity using R-CBA is a simple and rapid method for diagnosing TTP. The vWF-cp activity in patients with TTP was markedly lower than those of patients with tumors.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第6期818-822,共5页 中华医学杂志(英文版)
关键词 von Willebrand factor·cleaving protease·collagen binding assay·thrombotic thrombocytopenic purpura·tumor von Willebrand factor·cleaving protease·collagen binding assay·thrombotic thrombocytopenic purpura·tumor
  • 相关文献

参考文献10

  • 1OleksowiczL,BhagwatiN,DeLeonFernandez,etal.DificientactivityofvonWillebrand’sfactor cleavingproteasein patientswithdisseminatedmalignancies[].Cancer Research.1999
  • 2StudtJD,BhmM,BuddeU ,etal.MeasurementofvonWillebrandfactor cleavingprotease (ADAMTS13)activityin plasma:amulticentercomparisonofdifferentassaymethods[].JThrombHaemost.2003
  • 3Furlan M,Robles R,Galbusera M,et al.von Willebrand factorcleaving protease in thrombotic thrombocyto-penic purpura and the hemolytic-uremic syndrome[].The New England Journal of Medicine.1998
  • 4Tsai HM,Lian EC.Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura[].The New England Journal of Medicine.1998
  • 5Zheng X,Chung D,Takayama T K,et al.Structure of von Willebrand factor-Cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura[].Journal of Biological Chemistry.2001
  • 6Moake JL.Thrombotic microangiopathies[].The New England Journal of Medicine.2002
  • 7Mannucci PM,Karimi M,Mosalaei A,et al.Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS13 (von Willebrand factor cleaving protease)[].Haematologica.2003
  • 8Xi X,Ruan C,Li P, et al.Use of monoclonal antibodies in enzyme-linked immunoassay for von Willebrand factor[].Chin J Med Lab Sci.1988
  • 9Tsai HM.High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura[].American Journal of Hematology.2000
  • 10Rock G,Porta C,Bobbio-Pallavicini E,et al.Thrombotic thrombocytopenic purpura treatment in year 2000[].Haematologica.2000

同被引文献28

引证文献15

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部